The following adverse reactions have been reported from clinical trial and post-marketing experience. However, of those adverse reactions reported in company sponsored clinical trials, only headache, diarrhea, abdominal pain, asthenia, flatulence, rash and dry mouth were associated with the use of Rabeprazole (PARIET) Tablets. Frequencies are defined as: common (>1/100, <1/10), uncommon (>1/1,000, <1/100), rare (>1/10,000, <1/1,000) and very rare (<1/10,000). (See table.)

There have been post-marketing reports of bone fractures and post-marketing reports of subacute cutaneous lupus erythematosus (SCLE) (See Precautions).
View ADR Reporting Link